Publications (57) SAMUEL NAVARRO FOS publications

filter_list Internal Medicine

2025

  1. Primary Visceral Ewing Sarcoma (Gastric and Bladder) with KIT Expression: A Report of Two Patients and a Differential Diagnostic Approach

    International Journal of Surgical Pathology

  2. Tackling ALT-positive neuroblastoma: is it time to redefine risk classification systems? A systematic review with IPD meta-analysis

    Neoplasia (United States), Vol. 60

2024

  1. Characterization of Vitronectin Effect in 3D Ewing Sarcoma Models: A Digital Microscopic Analysis of Two Cell Lines

    Cancers, Vol. 16, Núm. 19

  2. Refining Risk Criteria May Substantially Reduce Unnecessary Additional Surgeries after Local Resection of T1 Colorectal Cancer

    Cancers, Vol. 16, Núm. 13

  3. Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker?

    International Journal of Molecular Sciences, Vol. 25, Núm. 16

2023

  1. Evaluation of Alternative Risk Stratification Systems in a Large Series of Solitary Fibrous Tumors with Molecular Findings and Ki-67 Index Data: Do They Improve Risk Assessment?

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

  2. Intimal Sarcoma with MDM2/CDK4 Amplification and p16 Overexpression: A Review of Histological Features in Primary Tumor and Xenograft, with Immunophenotype and Molecular Profiling

    International Journal of Molecular Sciences, Vol. 24, Núm. 8

2022

  1. Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness

    Frontiers in Cell and Developmental Biology, Vol. 10

2021

  1. Neuroendocrine differentiation in a large series of genetically-confirmed Ewing's sarcoma family tumor: Does it provide any diagnostic or prognostic information?

    Pathology Research and Practice, Vol. 219

  2. Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology

    Revista Espanola de Patologia, Vol. 54, Núm. 1, pp. 41-54

2020

  1. Controversial issues in soft tissue solitary fibrous tumors: A pathological and molecular review

    Pathology International, Vol. 70, Núm. 3, pp. 129-139

  2. Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line

    Journal of Experimental and Clinical Cancer Research, Vol. 39, Núm. 1

  3. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology

    Clinical and Translational Oncology, Vol. 22, Núm. 11, pp. 1976-1991

2019

  1. Assessing molecular subtypes of gastric cancer: Microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implications

    ESMO Open, Vol. 4, Núm. 3

  2. Improving tumour budding evaluation in colon cancer by extending the assessment area in colectomy specimens

    Histopathology, Vol. 75, Núm. 4, pp. 517-525

  3. Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression

    Modern Pathology, Vol. 32, Núm. 2, pp. 306-313

2018

  1. 1p36 deletion results in a decrease in glycosaminoglycans which is associated with aggressiveness in neuroblastic tumors

    Histology and Histopathology, Vol. 33, Núm. 5, pp. 487-495

  2. 9-ING-41, a small-molecule glycogen synthase kinase-3 inhibitor, is active in neuroblastoma

    Anti-Cancer Drugs, Vol. 29, Núm. 8, pp. 717-724

  3. HLA-DQ: Celiac disease vs inflammatory bowel disease

    World Journal of Gastroenterology, Vol. 24, Núm. 1, pp. 96-103

  4. Integrating Downstaging in the Risk Assessment of Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: Validation of Valentini's Nomograms and the Neoadjuvant Rectal Score

    Clinical Colorectal Cancer, Vol. 17, Núm. 2, pp. 104-112.e2